This opportunity is no longer accepting applications.
grant PAR-22-028
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
This grant offers researchers access to specialized research and medical organizations and experts to help them plan, manufacture, and conduct preliminary therapeutic development for ultra-rare gene-based therapies.
The purpose of this FOA is to provide investigators with a mechanism to access contract research/medical organizations (CROs/CMOs) and subject matter experts (SMEs) within the NINDS Ultra-Rare Gene-based Therapy (URGenT) Network to support planning, manufacturing, and limited nonclinical therape…
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute of Neurological Disorders and Stroke
Program: SBIR
Dates
Opportunity Released: November 9, 2021
Open for Submission: November 9, 2021
Submission Deadline: January 24, 2025
Application Window Closes: January 24, 2025
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers